Abstract
In this work, the analysis of the healing time of gastroduodenal ulcers after combined endoscopic hemostasis and the combined use of endoscopic and endovascular techniques for stopping bleeding was performed. Bleeding is severe, with a difficult to predict outcome, a complication of chronic gastric and duodenal ulcers. Despite the appearance of highly effective antisecretory drugs on the pharmacological market, the number of patients with bleeding gastroduodenal ulcer continues to grow. Currently, more than 1,500 patients with ulcerative gastroduodenal bleeding are hospitalized in St. Petersburg hospitals throughout the year. Of these, about 45 % are people over the age of 65, and more than 30 % have a moderate or severe comorbidity index, which significantly worsens the prognosis. Currently, the priority treatment methods for bleeding gastroduodenal ulcers are endoscopic and hybrid hemostasis technologies that combine endoscopic and endovascular procedures that provide completely satisfactory immediate results. The frequency of recurrent bleeding from chronic gastroduodenal ulcers after combined endoscopic hemostasis techniques does not exceed 3–5 %. The combination of endoscopic and endovascular technologies (ET) reduces the number of relapses to a minimum. This reduced operational activity to 1.5–2 % and mortality to 2–3 %. Currently, the timing of ulcer healing after various endoscopic and endovascular hemostasis techniques has not been sufficiently studied.